Sustained Release Excipients Market - Strategic Insights and Forecasts (2026-2031)

Sustained Release Excipients Market, sustaining a 7.55% CAGR, is anticipated to reach USD 2.536 billion in 2031 from USD 1.639 billion in 2025.

In contrast to an immediate-release dose, a sustained release excipients dosage provides a medication after ingestion or over a longer length of time, such as an extended-release. The sustained-release drugs are frequently employed in tablets and capsules. Delivery is often achieved by the active compound's excipient dissolving, deteriorating, or integrating. Release profiles can also be changed by encapsulation techniques like enteric coating.

Sustained Release Excipients Market Growth Drivers:

• Growth drivers for sustained release excipients market

The sustained release excipients market's expansion has been significantly impacted by the rising number of patent expirations and the rising need for dosage forms for the elderly and pediatric populations. As patient expectations for greater convenience rise, so does the need for controlled-release formulations. The primary ingredients in controlled-release formulations are excipients. The business is expected to be driven by growing public awareness of the additional advantages of controlled-release formulations. Excipients that aid the drug's prolonged release are used to create medications from a variety of active medicinal substances.

• The transdermal sustained-release delivery method shows growth potential

Transdermal sustained-release delivery methods are stronger and have a longer shelf life than the other types of excipients used in various medical compositions. Pharmaceutical polymers have improved over the past several years from being used to make simple gelatin capsules to strengthening excipient capsules with good formulation qualities that promote controlled/sustained release and help with medication distribution to target locations. Additionally, a surge in the number of formulations utilizing polyethylene glycol over the past few years has led to significant demand for the substance. Thus, it is predicted that increased polymer use would promote sustained release excipients market.

• Increasing use of oral drugs

Oral drug delivery methods are used more in contrast to other delivery methods due to the availability of the highest active surface for drug absorption. Additionally, the simplicity of producing capsules and tablets is another factor influencing the sustained release excipients market share. Excipients that aid the drug's prolonged release are used to create medications from a variety of active medicinal substances. If a producer is creating a sustained-release version of an already-known chemical, getting FDA clearance is not too difficult.

• Global rise in antibiotic resistance

The main contributors to antibiotic resistance have been recognized as excessive and improper usage of traditional medication formulations. Sometimes after receiving medication, patients get better quickly and stop taking the prescribed dosage, which leads to resistance. Such resistance causes an increase in the mortality rate, longer hospital stays, and higher medical expenses. Antibiotic resistance has also been brought on by the growth in the prevalence of infectious and chronic illnesses, which has had a detrimental effect on the market for traditional dosage forms. As a result, various methods of treating and controlling these disorders are being used which impacts the sustained release excipients market share.

Sustained Release Excipients Market Opportunity:

The largest subset of the drug delivery business, oral medication delivery, is growing rapidly. As a result, the oral delivery drug market with an expected growth of up to ten percent annually. Pharmaceutical companies are turning to drug delivery to the extent of the revenue-earning of their products and the increase in the elderly population. The market for oral-delivery pharmaceuticals is definitively broken out under Oral Delivery.

Sustained Release Excipients Market Geographical Outlook:

• The North American sustained release excipients are anticipated to grow significantly.

The North American sustained release excipients industry is anticipated to grow at a constant CAGR and keep the top spot for the whole period of the prediction. Presence of various pharmaceutical businesses and increased R&D efforts are fueling the North American sustained release excipients industry. The sustained release excipients market expansion in North America is further supported by growing regional cooperation between healthcare organizations to raise awareness of chronic illnesses and accessible treatment choices.

• Asia Pacific region is predicted to show growth potential

The quickly evolving healthcare system in the Asia Pacific region is fueling the sustained release excipients industry. Additionally, numerous infectious illnesses and extremely potent treatments upsurge the market. Particularly in the Asia Pacific area, China is a rising sustained release excipients market. To take advantage of this, the majority of worldwide excipient suppliers are proposing to set up production facilities in the nation. These are a few of the elements influencing the APAC region's expansion.

List of Top Sustained Release Excipients Companies:

To increase their market position, key firms are putting numerous tactics into practice, such as alliances formed through mergers and acquisitions, regional expansions, and strategic collaborations. DuPont successfully combined its Nutrition & Biosciences Business with International Flavours & Fragrances in February 2021. The range has expanded with the inclusion of Aquacoat products, increasing the number of options available to satisfy market demands. Many such product innovations are being made by the players which is upsurging the sustained release excipients market share.

Sustained Release Excipients Market Scope: